Submitted by Anonymous (not verified) on 24 March 2026 - 16:30
Human medicines European public assessment report (EPAR): Stivarga, regorafenib, Date of authorisation: 26/08/2013, Revision: 24, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Stivarga, regorafenib, Date of authorisation: 26/08/2013, Revision: 24, Status: Authorised